Verified peer comparison
Zentalis Pharmaceuticals vs Silvercrest Asset Management Group Financial Comparison
Direct answer
Zentalis Pharmaceuticals and Silvercrest Asset Management Group are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Zentalis Pharmaceuticals Revenue
- 0 USD
- Silvercrest Asset Management Group Revenue
- 125,319,000 USD
- Zentalis Pharmaceuticals Operating income
- -152,808,000 USD
- Silvercrest Asset Management Group Operating income
- 9,325,000 USD